Italiano Farmacia on line: comprare cialis senza ricetta, acquistare viagra internet.

Publications

Publications. Thore Egeland

Updated Sept 4, 2013

Submitted 2013
• Slooten K, Egeland T. Exclusion probabilities and likelihood ratios with applications to • Egeland T, Dørum G, Vigeland MD, Sheehan N. Mixtures with relatives: a pedigree • Kaur N, Fonneløp AE, Egeland T. Regression Models for DNA-mixtures • Dørum G; Øyvind Bleka; Peter Gill; Hinda Haned; Lars Snipen; Solve Sæbø; Thore Egeland. Exact computation of the distribution of likelihood ratios with forensic applications. 2013
1. Avershina E, Storrø O, Oien T, Johnsen R, Wilson R, Egeland T, Rudi K: Bifidobacterial succession and correlation networks in a large unselected cohort of mothers and their children. Appl Environ Microbiol. 2013 Jan;79(2):497-507. doi: 10.1128/AEM.02359-12. Epub 2012 Nov 2. ] 2. Egeland, T, Pinto, N, Vigeland MD. A general approach to power calculation for relationship testing. FSI: Genetics. Jun 27. doi:pii: S1872-4973(13)00111-7. 10.1016/j.fsigen.2013.05.001. [Epub ahead of print] 3. Pinto, N, Gusmão, L, Egeland, T, Amorim, A. (2013). Paternity exclusion power: Comparative behaviour of autosomal and X-chromosomal markers in standard and deficient cases with inbreeding. Forensic Science International: Genetics, 7(2), 290-295. [A] 2012
1. Kling D, Egeland T, Tillmar AA user friendly software for linkage calculations in family genetics. Forensic Science International: Genetics, 2012, 6(5): 616-620. 2. Kling D, Welander J, Tillmar A, Skare O, Egeland T, Holmlund G: DNA microarray as a tool in establishing genetic relatedness-Current status and future prospects. Forensic Science International: Genetics, 2012. May;6(3):322-9. 3. Kling D, Egeland T, Mostad P: Using object oriented bayesian networks to model linkage, linkage disequilibrium and mutations between STR markers. PLoS One. 2012;7(9):e43873. doi: 10.1371/journal.pone.0043873. Epub 2012 Sep 11. 4. Selmer KK, Gilfillan GD, Strømme P, Lyle R, Hughes T, Hjorthaug HS, Brandal K, Nakken S, Misceo D, Egeland T: A mild form of Mucopolysaccharidosis IIIB diagnosed with targeted next-generation sequencing of linked genomic regions. European Journal of Human Genetics 2012, 20(1):58-63. 5. Egeland T, Fonneløp AE, Berg PR, Kent M, Lien S. Complex mixtures: A critical examination of a paper by Homer et al. Forensic Science International: Genetics. 1 Letters A-G (not all appear in this list) are used to classify papers. A: Original scientific peer reviewed paper; B: Other scientific paper; C: Review, book-chapter, etc; G: Miscellaneous (not scientific paper) 6. Egeland T, Samuelsen, SO: Geir Storvik 50 år. Tilfeldig Gang, nr. 3, årgang 29, desember 7. Vigeland MD, Selmer KK, Egeland, T: Statistical methods in genetics. Book chapter in Medical statistics in clinical and epidemiological research, ed Marit B. Veierød, Stian Lydersen, Petter Laake, Gyldendal Akademisk 2012. 8. Toscanini U, Garcia-Magariños M, Berardi G, Egeland T, Raimondi E, Salas A: Evaluating methods to correct for population stratification when estimating paternity indexes. PLoS One. 2012;7(11):e49832. doi: 10.1371/journal.pone.0049832. Epub 2012 Nov 30. 2011
1. Egeland T, Dawid AP, Mortera J, Mostad P, Tillmar A Investig Genet. 2011 Mar 25;2(1):7. letter 2. Egeland T. Genetiske spørsmål – statistiske svar. Tidsskr Nor Legeforening 2011 3. Eide H, Sibbern T, Egeland T, Finset A, Johannessen T, Miaskowski C, Rustøen T. 4. Haned H, Egeland T, Pontier D, Pène L, Gill P Forensic Sci Int Genet. 2011 Jan 7. [A] 5. Egeland T, Salas A: A Statistical Framework for the Interpretation of mtDNA Mixtures: Forensic and Medical Applications. PloS one 2011, 6:e26723. 6. Tillmar AO, Egeland T, Lindblom B, Holmlund G, Mostad P: Using X-chromosomal markers in relationship testing: Calculation of likelihood ratios taking both linkage and linkage disequilibrium into account. Forensic Science International: Genetics 2011 Nov;5(5):506-11. [A] 1. Wangensteen T, Egeland T, Akselsen H, Holmen J, Undlien DE, Retterstøl L. FTO genotype and weight gain in obese and normal weight adults from a Norwegian population based cohort (the HUNT study). Experimental and Clinical Endocrinology & Diabetes 2010 April 6. [A] 2. Skinningsrud B, Lie B, Husebye ES, Kvien, TK,Førre, Ø, Flatø B, Stormyr A; Joner G; Njølstad PR, Egeland T, Undlien DE. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis. Annals of the Rheumatic Diseases 2010; Volum 69.(8). [A] 2009

1. Selmer KK, Eriksson AS, Brandal K, Egeland T, Tallaksen C, Undlien DE. Parental SCN1A mutation mosaicism in familial Dravet syndrome. Clin Genet 2009;76:398-403. [A] 2. Skare O, Sheehan N, Egeland T. Identification of distant family relationships. Bioinformatics 2009;25:2376-82.
3. Bjørnvold M, Munthe-Kaas MC, Egeland T, Joner G, Dahl-Jørgensen K, Njølstad PR, Akselsen HE, Gervin K, Carlsen KC, Carlsen KH, Undlien DE. A TLR2 polymorphism is associated with type 1 diabetes and allergic asthma. Genes Immun 2009;10:181-7. [A] 4. Egeland T. Tidsskrift for Strafferett 2009;2: 5. Selmer KK, Brandal, K, Olstad OK, Birkenes, B, Undlien, DE, Egeland, T. Genome Wide Linkage Analysis With Clustered SNP Markers. The Journal of Biomolecular Screening 2009;14:92-6. [A] 2008

1. Egeland T, Salas A . Statistical evaluation of haploid genetic evidence 2. Sheehan, NA and T. Egeland. Adjusting for founder relatedness in linkage analysis using prior information. Hum Hered 2008;65:221–231. 3. Egeland T, Sheehan, NA. On identification problems requiring linked autosomal markers. Forensic Science International: Genetics: 2008;2:219–225. Errata. Equation (4) is misaligned with the pedigrees of Figure 1. The two last equations of Equation (4) should be swapped to read as show 4. Gilfillan GD, Selmer KK, Roxrud I, Smith R, Kyllerman M, Eiklid K, Kroken M, Mattingsdal M, Egeland T, Stenmark H, Sjøholm H, Server A, Samuelsson L, Christianson A, Tarpey P, Whibley A, Stratton MR, Futreal PA, Teague J, Edkins S, Gecz J, Turner G, Raymond FL, Schwartz C, Stevenson RE, Undlien DE, Strømme P. Mutations Cause X-Linked Mental Retardation, Microcephaly, Epilepsy, and Ataxia, a Phenotype Mimicking Angelman SyndromeJ Hum Genet 2008;82:1003-10. [A] 5. Skinningsrud B, Husebye ES, Gervin K, Løvås K, Blomhoff A, Wolff AB, Kemp EH, Egeland T, Undlien DE. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur J Hum Genet 2008;16:997-82. [A] 6. Munthe-Kaas MC, Carlsen KH, Håland G, Devulapalli CS, Gervin K, Egeland T, Carlsen KL, Undlien DE. T cell–specific T-box transcription factor haplotype is associated with allergic asthma in children.Journal of Allergy and Clinical Immunology 121.1 (2008): 51-56. [A] 7. Selmer KK, Egeland T, Solaas MH, Nakken KO, Kjeldsen MJ, Friis ML, Brandal K, Corey LA, Undlien DE. Genetic screening of Scandinavian families with febrile seizures and epilepsy or GEFS+. Acta Neurol Scand 2008;117:289-92. [A] 8. Skinningsrud B, Husebye ES, Pearce SH, McDonald DO, Brandal K, Bøe Wolff A, Løvås K, Egeland T, Undlien DE. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J Clin Endocrinol Metab 2008;93:3310-7. [A] 9. Tillmar A, Mostad P, Egeland T, Lindblom B, Holmlund G, Montelius K. Analysis of linkage and linkage disequilibrium for eight X-STR markers. Forensic Sci Int Genet 2008;3:37-41. [A] 10. Egeland T, Salas A. Estimating Haplotype Frequency and Coverage of Databases. PLoS 11. Selmer KK, Egeland T, Solaas MH, Nakken KO, Kjeldsen MJ, Friis ML, Brandal K, Corey LA, Undlien DE. Comment. Acta Neurol Scand. 2008 [B], letter 2007

2. Karlsson A, Holmlund G, Egeland T, Mostad P. DNA-testing for immigration cases Forensic Science International 2007;172:144-9. 3. Sheehan NA. Egeland T. Structured incorporation of prior information in relationship identification problems. Ann Hum Genet 2007;71:501-18. 4. Munthe-Kaas MC, Gerritsen J, Carlsen KH, Undlien D, Egeland T, Skinningsrud B, Torres T, Carlsen KL. Eosinophil cationic protein (ECP) polymorphisms and association with asthma, s-ECP levels and related phenotypes. Allergy 2007;62:429-36. [A] 5. Munthe-Kaas MC, Carlsen KL, Carlsen KH, Egeland T, Haland G, Devulapalli CS, Akselsen H, Undlien D. HLA Dr-Dq haplotypes and the TNFA-308 polymorphism: associations with asthma and allergy. Allergy 2007;62:991-8. [A] 6. Haraldsen IR, Haug E, Falch J, Egeland T, Opjordsmoen S. Cross-sex pattern of bone mineral density in early onset gender identity disorder. Horm Behav 2007;52:334-43. [A] 7. Egeland, T, Haugen, TTidsskr Nor Lægeforen 2007;127: 733-4. . 8. Laake P, Egeland T, Skovlund EResearch Methodology in the Medical and Biological Sciences . Ed. Laake, Benestad and Olsen, Elsevier, 2007. [ C], book chapter 2006

1. Haugen TB, Egeland T, Magnus O. Semen parameters in Norwegian fertile men. J Androl 2. Skari H, Malt UF, Bjornland K, Egeland T, Haugen G, Skreden M, Dalholt Bjork M, Bjornstad Ostensen A, Emblem R. Prenatal diagnosis of congenital malformations and parental psychological distress—a prospective longitudinal cohort study. Prenat Diagn 2006;26:1001-9. [A] 3. Egeland T, Kulle B, Andreassen, R. Essen-Möller and identification based on DNA 2005

1. Albrechtsen S, Berge LN, Bordahl PE, Egeland T, Henriksen T, Haheim LL, Oian P. External cephalic version of breech presentation at term. Tidsskr Nor Laegeforen 2005 Mar 3;125(5):589-90. [B] 2. Mjaland O, Normann E, Halvorsen E, Rynning S, Egeland, T. Regional cerebral perfusjon før og etter paratyreoidektomi. Tidsskr Nor Laegefore. 2005 Jan 6;125(1):33-5. [B] 3. Lien G, Selvaag AM, Flato B, Haugen M, Vinje O, Sorskaar D, Dale K, Egeland T, Forre O. A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis. Arthritis Rheum 2005;52:833-40. [A] 4. Ronnestad A, Abrahamsen TG, Medbo S, Reigstad H, Lossius K, Kaaresen PI, Egeland T, Engelund IE, Irgens LM, Markestad T. Late-onset septicemia in a Norwegian national cohort of extremely premature infants receiving very early full human milk feeding. Pediatrics 2005;21:269-76. [A] 5. Haraldsen IR, Egeland T, Haug E, Finset A, Opjordsmoen S. Cross-sex hormone treatment does not change sex-sensitive cognitive performance in gender identity disorder patients. Psychiatry Res 2005;137:161-74. [A] 2004
1. Jahnsen, Reidun; Villien, L.; Egeland, T; Stanghelle, J K.; Holm, I. Locomotion skills in adults with cerebral palsy. Clinical Rehabilitation 2004;18:309-316. [A] 2. Haheim LL, Albrechtsen S, Berge LN, Bordahl PE, Egeland T, Henriksen T, Øian P. Breech birth at term: vaginal delivery or elective cesarean section? A systematic review of the literature by a Norwegian review team. Acta Obstet Gynecol Scand 2004;83:126-130. [A] 3. Dupuy BM, Stenersen M, Egeland T, Olaisen B. Y-chromosomal microsatellite mutation rates: differences in mutation rate between and within loci. Hum Mutat 2004;23:117-24. [A] 4. Egeland,T, Bøvelstad HM, Storvik G and Salas A. Inferring the most likely geographical origin of mtDNA sequence profiles. Annals of Human Genetics 2004;68: 461-471. 5. Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 2004;47:1550-6. [A] 6. Midtvedt K, Hjelmesaeth J, Hartmann A, Lund K, Paulsen D, Egeland T, Jenssen T. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J Am Soc Nephrol 2004;15:3233-9. [A] 7. Laake P, Egeland T. Statistisk analyse av kategoriske data. Bokkapittel i Forskningsmetode i medisin og biofag, Gyldendal, Akademisk, red. Laake og Benestad, 2004. [ C], book chapter 2003
1. Hjelmesaeth J, Jenssen T, Hagen M, Egeland T, Hartmann A. Determinants of insulin secretion after renal transplantation. Metabolism 2003;52:573-578. [A] 2. Mjaland O, Normann E, Halvorsen E, Rynning S, Egeland T. Regional cerebral blood flow in patients with primary hyperparathyroidism before and after successful parathyroidectomy. Br J Surg 2003;90:732-7. [A] 3. Haraldsen IR, Opjordsmoen S, Egeland T, Finset A. Sex-sensitive cognitive performance in untreated patients with early onset gender identity disorder. Psychoneuroendocrinology 2003;28:906-15. [A] 4. Lien G, Flato B, Haugen M, Vinje O, Sorskaar D, Dale K, Johnston V, Egeland T, Forre O. Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients. Arthritis Rheum 2003;48:2214-23. [A] 5. Egeland T, Dalen I, Mostad PF. Estimating the number of contributors to a DNA profile. Int 6. Boberg KM, Egeland T, Schrumpf E. Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients. Scand J Gastroenterol 2003;38:991-5. [A] 7. Fell AK, Thomassen TR, Kristensen P, Egeland T, Kongerud J. Respiratory symptoms and ventilatory function in workers exposed to portland cement dust. J Occup Environ Med 2003;45:1008-14. [A] 8. Nord C, Fossa SD, Egeland T. Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer. Br J Cancer 200313;88:36-41. [A] 9. Jahnsen R, Haugen, L, Villien L, Egeland T, Stanghelle J K, Holm I. Kommer hun til å kunne gå? CP bladet 2003;1:3-4. [C] 10. Øian P, Albrechtsen S, Berge LN, Børdahl PE, Egeland T, Henriksen T, Håheim LL. Term breech delivery- Assisted vaginal delivery or cesarean section? Norwegian Centre for Health Technology Assessment. Report no. 3/ 2003, pp.1-120. [C] 2002
1. Egeland T, Mostad PF. Statistical genetics and genetical statistics: a forensic perspective. Scandinavian Journal of Statistics 2002;29:297-307. 2. Hjelmesaeth J, Hagen M, Hartmann A, Midtvedt K, Egeland T, Jenssen T. The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation. Clin Transplant 2002;16:389-96. [A] 3. Boberg KM, Bergquist A, Mitchell S, Pares A, Rosina F, Broome U, Chapman R, Fausa O, Egeland T, Rocca G, Schrumpf E. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 2002;37:1205-11. [A] 4. Skari H, Skreden M, Malt UF, Dalholt M, Ostensen AB, Egeland T, Emblem R. Comparative levels of psychological distress, stress symptoms, depression and anxiety after childbirth--a prospective population-based study of mothers and fathers. BJOG 2002 Oct;109(10):1154-63. [A] 5. Hjelmesaeth J, Jenssen T, Egeland T, Hagen M, Hartmann A. Response to Montori et al. Post-taransplantation diabetes (PTD), risk factors for its development, prognostic implications, and optimal management of the disease. Diabetes Care 2002;25:1667; discussion 1667-8. [A] 6. Opdal SH, Vege A, Egeland T, Musse MA, Rognum TO. Possible role of mtDNA mutations in sudden infant death. Pediatr Neurol 2002;27:23-29. [A] 7. Boberg KM, Rocca G, Egeland T, Bergquist A, Broomé U, Caballeria L, Chapman R, Hultcrantz R, Mitchell S, Pares A, Rosina F, Schrumpf EHepatology. 2002 Mar;35(3):652-7. [A] 8. Flato B, Smerdel A, Johnston V, Lien G, Dale K, Vinje O, Egeland T, Sorskaar D, Forre O. The influence of patient characteristics, disease variables, and HLA alleles on the development of radiographically evident sacroiliitis in juvenile idiopathic arthritis. Arthritis Rheum 2002;46:986-94. [A] 9. Nord C, Fossa SD, Egeland T. Young age as an important risk factor of excessive annual BMI increase in survivors of testicular cancer. Int J of Cancer 2002;13;373-374. [G] 2001

1. Saetre T, Høiby EA, Aspelin T, Lermark G, Egeland T, Svindland A, Lyberg T. Aminoethyl-isothiourea inhibits the increase in plasma endothelin-1 caused by serogroup a streptococci and prolongs survival in rat peritoneal sepsis. Shock 2001 Jun;15:446-52. [A] 2. Hjelmesæth J, Hartmann A, Midtvedt K, Aakhus S, Stenstrom J, Morkrid L, Egeland T, Tordarson H, Fauchald P. Metabolic cardiovascular syndrome after renal transplantation. Nephrol Dial Transplant 2001;16:1047-52. [A] 3. Hjelmesæth J, Hartmann A, Kofstad J, Egeland T, Stenstrom J, Fauchald P. Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. Nephrol Dial Transplant 2001;16:829-35. [A] 4. Dupuy BM, Andreassen R, Flones AG, Tomassen K, Egeland T, Brion M, Carracedo A, Olaisen B. Y-chromosome variation in a Norwegian population sample. Forensic Sci Int 2001;117:163-173. [A] 5. Egeland T. Selection and Causality. In Radiation, ed Brune et al., Scandinavian Science 2000

1. Egeland T, Mostad PF, Mevåg B, Stenersen M. 2. Celius EG, Harbo HF, Egeland T, et al. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. Journal of the neurological sciences 2000;178:132-135. [A] 3. Jørgensen B, Simonsen S, Endresen K, Forfang K, Egeland T, Thaulow E. Physiological response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty. Prediction of restenosis by exercise capacity. American Heart Journal 2000;139:482-90. [A] 4. Skari H, Bjornland K, Haugen G, Egeland T, Emblem R. Congenital diaphragmatic hernia: a meta-analysis of mortality factors. J Pediatr Surg 2000;35:1187-97. [A] 5. Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S,Broome U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E. The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. Scand J Gastroenterol 2000;36:886-90. [A] 6. Egeland T. Statistical Science in the Courtroom. Stat in Medicine 20 (14) 2001: Joseph L Gastwirth (ed.), Springer-Verlag, New York, 2000. , book review 7. Thelle D, Nilsson S, Egeland T. Genetisk epidemiologi. Epidemiologiske og kliniske forskningsmetoder 2000. Red: Laake, Hjartåker, Thelle, Veierød, Gyldendal Akademisk, Oslo. [C], book chapter 1999

1. Mugnaini EN, Egeland T, Spurkland A, Brinchmann JE. The T cell receptor repertoire of CD8+CD28- T lymphocytes is dominated by expanded clones that persist over time. Clin Exp Immunol 1999 Aug;117(2):298-303. [A] 2. Mugnaini EN, Egeland T, Syversven AM, Spurkland A, Brinchmann JE.Molecular analysis of the complementarity determining region 3 of the human T cell receptor beta chain. Establishment of a reference panel of CDR3 lengths from phytohaemagglutinin activated lymphocytes. J Immunol Methods 1999;223:207-16. [A] 3. Boberg KM, Brosstad F, Egeland T, Schrumpf E. Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy? Thromb Haemost 1999;81:378-81. [A] 4. Jørgensen, B Simonsen S, Endresen K, Forfang K, Egeland T, Høstmark AT, Thaulow E. Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids. European Heart Journal 1999;20:1407-14. [A] 5. Westergren T, Abrahamsen T, Egeland T. Forbruk av antiinfeksiøse legemidler ved
barneavdelingene i helseregion 2. Tidsskr Nor Lægeforen. 1999;18:2640-4. 1998

1. Opdal SH, Rognum TO, Vege AA , Stave AK, Dupuy BM, Egeland T. Increased number of substitutions in the D-loop of mitochondrial DNA in the sudden infant death syndrome. Acta Pædiat 1998;87:1039-44. [A] 2. Diseth T, Egeland T, Emblem R. Effects of Anal Invasive Treatment and Incontinence on Mental health and Psychososial Functioning of Adolescents with Hirschsprung's Disease and Low Anorectal Anomalies. J Pediatric Surgery 1998;33:468-475. [A] 3. Egeland T, Mevåg B, Stenersen M, Mostad PF. Tallfesting av beviskraften i DNA. Nordisk Rettsmedisin 1998;4:85-108. , review 4. Mugnaini EN, Spurkland A, Egeland T, Sannes M, Brinchmann J.E. Demonstration of identical expanded clones within both CD8 and CD28 and CD8 and CD28 T cell subsets in HIV type 1-infected individuals. Eur J Immunol 1998;28:1738-1742. [A] 5. Lote K, Egeland T, Hager B, Skullerud K, Hirschberg, H. Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma. J Neurooncol 1998;40:161-70. [A] 6. Lote K, Egeland T. Published and Perished- The Lote-Egeland Theorem. J of Irreproducible Results. 1998;43:29-31. 1997

1. Moser MB, Trommald M, Egeland T, Andersen P. Spatial training in adult rats is followed by increased spine synapse density in a subset of CA1 pyramidal cells. J Comp Neurol 1997;380:373-381. [A] 2. Hjelmesæth J, Hartmann A, Kofstad J, Stenstrøm J, Leivestad T, Egeland T, Fauchald P. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997;64:979-983. [A] 3. Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, Storm Mathisen I, Hirschberg H. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 1997 9:3129-3140. [A] 4. Egeland T, Hoff-Olsen P, Magnus Ø. Excessive use of a single donor? And inadvertent consanguinity. Fertil Steril 1997 676;1181-1183. letter 5. Lia O, Omre H, Tjelmeland H, Holden L, Egeland T. Uncertainties in reservoir production forecasts. AAPG Bulletin-American Association of petroleum geologists 1997;81:775-802. [A] 6. Egeland T, Mostad PF, Olaisen B. A computerised method for calculating the probability of pedigrees from genetic data. Science Justice 1997;37:269-274. 7. Foss Abrahamsen A, Egeland T, Hansen S, Langholm R, Holte H, Kvaløy S. Hodgkin's disease in a national and hospital population: Trends over 20 years. European J of Cancer 1997;33:2380-2383. [A] 8. Aalen O.O, Egeland T. Ufortjent skinn av objektivitet. Aftenposten, 16/12/97.
1996

1. Andreassen R, Egeland T, Olaisen B. Mutation rate in the hypervariable VNTR g3 (D7S22) is affected by allele length and a flanking DNA sequence of polymorphism near the repeat array. American Journal of Human Genetics, 59(2): 360-7, 1996. [A] 2. Mostad PF, Egeland T, Hjort NL, Kraggerud AG, Biver P. Variogram estimation in a Bayesian framework. Proc. 5 Int. Geostatistics Congress, Sept. 1996, Wollongong, Australia. [B]
1995

1. Bølviken E, Egeland T. Arson, statistics and the law: Can the defendant's proximity to a large number of fires be explained by chance? Science and Justice 1995;35:97-104. 2. Egeland T, Georgsen F, Skare Ø, Alabert F. Analytical calculations related to facies simulation. Mathematical Geology 1995;27(3): 391-398. 3. Egeland T. Matematiske og statistiske aspekter ved farskapsdiagnostikken ved Rettsmedisinsk Institutt i Oslo (RMI). SAND/09/95. Norwegian Computing Centre, Report. [B] 1994

1. Egeland T. When is a system better than the average of its components? Probability in the engineering and information sciences 1994;3:431-434. [A] 2. Larsen E, Kristoffersen S, Egeland T. Functional integration in design and use of a system for design of statistical experiments. EPCC 94, European petroleum computer conference. Proceedings. Aberdeen, U.K. March 15-17, 431-439, 1994. [B] 3. Egeland T, Holden L. Datamaskinen som laboratorium. Normat (Nordisk Matematisk Tidsskrift) 1994;42:19-24. [C], review 1993

1. Egeland T, Eide A, Holden L. Automatic history matching. NR Notat, SAND/08/93, 1993. 78 s. Norwegian Computing Centre, Report. [B] 2. Damsleth E, Egeland T, Henriquez A. Landbruk og petroleum. Teknisk Ukeblad, no 31, 3. Egeland T, Georgsen F, Knarud R, Omre H. Multi facies modelling of fluvial reservoirs. 68th Annual Technical Conference and Exibition of the Society of Petroleum Engineers. Proceedings.Houston, TX . October 3-6, 863-872, 1993. [B] 4. Georgsen F, Egeland T, Knarud R, Omre H. Conditional simulation of facies architecture in fluvial reservoirs. Workshop on geostatistical simulations. Proceedings. Fontainebleau, France. May 27-28, 235-250, 1993. [B] 5. Solberg R, Egeland T. Automatic feature selection in hyperspectral satellite imagery. IGARSS'93 Conference. Proceedings.Tokyo. Aug.18-21, A1-A4, 1993. [B] 6. Storvik G, Egeland T, Holden L, Tjelmeland, H. Markov Chain simulations for analysis of marked point processes. NR Rapport, no 869, 1993. 34 s. ISBN: 82-539-0364-2. [B] 1993
1. Egeland T. On the S-shaped theorem. Statistics and probability letters 1992;13:1-4. [A] 2. Egeland T. Mixing dependence and system reliability. Scandinavian Journal of Statistics. 3. Egeland T. Pålitelighetsanalyse og risikoanalyse. Tilfeldig Gang. 1992. [C], book review 4. Abrahamsen P, Egeland T, Lia O, Omre H. An integrated approach to prediction of hydrocarbon in place and recoverable reserve with uncertainty measures. First SPE European Petroleum Computer Conference. Proceedings SPE 24276 1992:151-161. [B] 5. Egeland T, Hatlebakk E, Holden L, Larsen E. Designing better decisions. First SPE European Petroleum Computer Conference. Proceedings SPE 24275. Stavanger, pp 143-150, 1992. [B] 1991
1. Egeland T. Two trends in reliability. Structural Safety 1991;9:261-268. [A] 2. Egeland T. Tunge beregninger og forsøksplanlegging. InfoTech '91, Den norske 1985-1990

1. Madsen HO, Egeland T. Structural reliability - models and applications. International Statistical Review 1989;54:185-203. [C], review 2. Egeland T. On dependence and system reliability. University of Oslo, 1989. [B], PhD 3. Egeland T, Tvedt L. Parallel systems of series subsystems. In Reliability and optimization of structural systems, ed. P.Thoft-Christensen, Springer, 109-118, 1987. [B], book chapter 4. Egeland T, Madsen HO, Slatcher S. Probabilistic analysis of the Oseberg GBS foundation against failure in cyclic loading. Veritas Research report, no 86-2012, 1986. [B] 5. Egeland T. Dependence and ist consequences for reliability calculations. Cand. scient thesis. University of Oslo, 1985. [B]

Source: http://arken.umb.no/~theg/publicationsEgelandumb.pdf

Carta europea de salvaguarda de los derechos humanos en la ciudad

CARTA EUROPEA DE SALVAGUARDA DE LOS DERECHOS HUMANOS EN LA CIUDAD CARTA EUROPEA DE SALVAGUARDA DE LOS DERECHOS HUMANOS EN LA CIUDAD Dirigida a los hombres y las mujeres de la ciudad ¿Por qué, en el umbral del siglo XXI, una Carta Europea de los Derechos Humanos en la Ciudad? La Declaración de Derechos Humanos (1948) es universal. ¿No ha sido reforzada y completada por otros muc

farmavisa.wikispaces.com

NOTas FaRmaCOTeRapéUTICas Áreas 1, 2, 3 y 7 de Atención Primaria Servicio Madrileño de Salud - CoMunidAd de MAdrid Disponible en Internet http://www.madrid.org UTIlIzaCIóN De meDICameNTOs Vol. 15 Núm. 8 Año 2008 eN el aNCIaNO CONClUsIONes: Aproximadamente el 16% de la población en • Las enfermedades crónicas, comorbilidades y España tiene 65 o más años y l

Copyright © 2010-2014 Drugstore Pdf Search